Semaglutide SM30 30mg*10vials

Semaglutide SM30 30mg x 10 Vials

Product Overview

Semaglutide SM30 is the top-of-the-line upgraded flagship version of the Semaglutide SM series. It is a high-purity ultra-stable long-acting lyophilized GLP-1 receptor agonist peptide suitable for advanced preclinical metabolic studies. As the final iteration of SM10, SM15, and SM20, SM30 utilizes third-generation whole-molecule optimization technology, supporting saturated target binding efficiency, superior anti-degradation properties, and extended in vivo activity retention research. Its high concentration of 30mg per vial supports ultra-high dose gradient experiments, ultra-long-term metabolic modeling, large-scale batch replication validation, and extreme phenotypic mechanism studies. It serves as a high-quality core research ingredient for high-standard in-depth GLP-1 mechanism exploration and extreme dose-efficacy boundary studies.

Core Research Functions

Full-Effect GLP-1 Single-Target Activation Effect and Physiological Incretin Activity Stable Efficient Mimicry: Supports full-effect GLP-1 single-target activation effect research, body physiological incretin activity stable efficient mimicry studies.

Extreme Insulin Resistance Repair and Blood Glucose Homeostasis Long-Term Stable Regulation: Supports extreme insulin resistance repair exploration research, blood glucose homeostasis long-term stable regulation studies, and glucose and lipid metabolism pathways comprehensive remodeling research.

Stronger Appetite Suppression and Extended Satiety Maintenance: Supports stronger appetite suppression and extended satiety maintenance research, energy intake effective reduction related studies, and systemic lipid metabolism disorders and refractory fat accumulation deep intervention research.

More Saturated Biological Activity and More Extreme Experimental Phenotypes: Supports more saturated biological activity, more extreme experimental phenotypes, and more durable therapeutic stability research compared to conventional versions such as SM10, SM15, and SM20.

Ultra-Precise Highly Reliable Data Support for Advanced Research: Supports ultra-precise highly reliable data provision research for advanced research on severe refractory metabolic diseases, advanced endocrine regulatory mechanisms, and extreme dose-response relationships validation.

Semaglutide SM30 supports full-effect GLP-1 single-target activation effect research, body physiological incretin activity stable efficient mimicry studies. In advanced laboratory research, it is primarily used to explore extreme insulin resistance repair, blood glucose homeostasis long-term stable regulation, and glucose and lipid metabolism pathways comprehensive remodeling. It supports stronger appetite suppression and extended satiety maintenance research, energy intake effective reduction related studies, and systemic lipid metabolism disorders and refractory fat accumulation deep intervention research. Compared to conventional versions such as SM10, SM15, and SM20, SM30 supports more saturated biological activity, more extreme experimental phenotypes, and more durable therapeutic stability research, providing ultra-precise highly reliable data support for advanced research on severe refractory metabolic diseases, advanced endocrine regulatory mechanisms, and extreme dose-response relationships validation.

Core Product Advantages

SM30 Top-Tier Ultimate Upgrade: A fully optimized third-generation molecular structure with saturated target binding capacity. Its biological activity, molecular stability, and anti-attenuation capabilities support comprehensive surpass research compared to ordinary semaglutide and all lower-version SM series products, meeting stringent standards of high-end advanced scientific research.

30mg High Concentration Upper Limit: The highest specification of the SM series flagship product, with a concentration 3 times that of the conventional 10mg, 2 times that of 15mg, and 1.5 times that of 20mg. Suitable for ultra-high dose gradient extreme control experiments, ultra-long-term repeated animal models, and large-scale multi-group parallel experiments, supporting frequent dilution and solution changes caused data deviations related elimination research.

Advanced Full-Lock Lyophilization Process: Utilizes pharmaceutical-grade aseptic vacuum lyophilization technology to support peptide molecular activity stable retention research. Each batch undergoes rigorous full-category high-performance liquid chromatography HPLC purity testing and is accompanied by a complete Certificate of Analysis COA, supporting extremely low impurity residues and batch-to-batch variability related research.

Standardized 10-Bottle Bulk Packaging: Each box contains 10 bottles in integrated aseptic packaging, suitable for long-term strategic reserves in laboratories, core preclinical research and development of top-tier drugs, key university research projects, and large-scale global wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 30mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis COA.